The pharma wholesale and distribution market is estimated to grow at a CAGR of 5.6% in the first half of the forecast period. The market is estimated to reach a revenue of $1.3bn in 2023. In 2017, the branded drugs submarket held 79% of the pharma wholesale and distribution market.

Download Free Sample Pages of this report
 

How this report will benefit you
Read on to discover how you can exploit the future business opportunities emerging in this sector.

In this brand new 277-page report you will receive 93 tables and 107 figures– all unavailable elsewhere.

The 277-page report provides clear detailed insight into the pharma wholesale and distribution market. Discover the key drivers and challenges affecting the market.

By ordering and reading our brand-new report today you stay better informed and ready to act.

Report Scope
Global Pharma Wholesale and Distribution Market
from 2018-2028

Forecast of the Global Pharma Wholesale and Distribution market by Category:

  • Generic Drugs
  • Branded Drugs
  • Others

This report provides individual revenue forecasts to 2028 for these national markets:

  • US
  • Germany
  • France
  • Italy
  • pain
  • UK
  • Japan
  • China
  • Brazil
  • India
  • Russia
  • RoW

Each National Market is further segmented into generic drugs, branded drugs and others

Our study discusses the selected leading companies that are the major players in the global pharma and wholesale distribution market:

  • Alfresa Holdings
  • AmerisourceBergen
  • Cardinal Health
  • McKesson
  •  edipal
  • PHOENIX Group
  • Shanghai Pharma
  • SINOPHARM
  • Suzuken
  • Walgreens Boots Alliance
This report provides a SWOT and STEP analysis of the pharma wholesale and distribution market.

This study is intended for anyone requiring commercial analyses for the pharma wholesale and distribution market. You find data, trends and predictions.